Skip to main content
. 2023 Mar 2;12(5):1967. doi: 10.3390/jcm12051967

Table 2.

RPL Evaluation of abnormal results among women with index pregnancies.

Dydrogesterone Treatment
n = 509 *
No Dydrogesterone Treatment
n = 357 *
p-Value
Anatomical evaluation (Abnormal/Tested) 4.3 (6/141) 7.4 (2/27) 0.616
Karyotype (Abnormal/Tested) - (0/39) - (0/11) -
TSH (Abnormal/Tested) 10.3 (48/466) 6.1 (17/279) 0.063
Prolactin (Abnormal/Tested) 11.1 (26/234) 8.9 (8/90) 0.687
Glucose (Abnormal/Tested) 34.4 (33/96) 31.8 (7/22) 1.000
HbA1C (Abnormal/Tested) 6.9 (2/29) - (0/4) 1.000
Anti-thyroid peroxidase (Abnormal/Tested) 14.1 (26/185) 9.7 (6/62) 0.513
Antithyroglobulin (Abnormal/Tested) 7.8 (13/166) 12.1 (7/58) 0.421
Lupus anticoagulant (LAC) 2.3 (6/265) 1.6 (1/63) 1.000
ACL IgG
(Abnormal/Tested)
2.8 (7/250) 1.0 (1/99) 0.449
ACL IgM
(Abnormal/Tested)
2.0 (5/255) 1.0 (1/101) 1.000
A.B2 glycoprotein IgG
(Abnormal/Tested)
0.5 (1/219) 1.2 (1/85) 0.482
A.B2 glycoprotein IgM
(Abnormal/Tested)
1.8 (4/224) 6.9 (6/87) 0.032
Antinuclear Ab
(Abnormal/Tested)
10.2 (17/167) 8.1 (6/74) 0.813
Rheumatoid factor
(Abnormal/Tested)
5.5 (11/200) 8.4 (7/83) 0.423
Protein C
(Abnormal/Tested)
2.9 (5/170) 3.1 (2/65) 1.000
Protein S
(Abnormal/Tested)
22.2 (6/27) - (0/11) 0.154
Antithrombin 3
(Abnormal/Tested)
0.6 (1/165) 1.6 (1/64) 0.482
Factor V Leiden mutation
(Abnormal/Tested)
9.1 (3/33) 37.5 (3/8) 0.048
Prothrombin mutation
(Abnormal/Tested)
3.3 (1/30) - (0/7) 1.000

* Missing values: anatomical evaluation: n = 698; karyotype: n = 816; TSH: n = 121; prolactin: n = 542; glucose: n = 748; HbA1C: n = 833; anti-thyroid peroxidase: n = 619; antithyroglobulin: n = 642; LAC: n = 538; ACL IgG: n = 517; ACL IgM: n = 510; A.B2 glycoprotein IgG: n = 562; A.B2 glycoprotein IgM: n = 555; antinuclear Ab: n = 625; rheumatoid factor: n = 583; protein C: n = 631; protein S: n = 828; antithrombin 3: n = 637; factor V Leiden mutation: n = 825; mutation prothrombin: n = 829.